<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Med</journal-id><journal-title>BMC Medicine</journal-title><issn pub-type="epub">1741-7015</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">16115311</article-id><article-id pub-id-type="pmc">1198229</article-id><article-id pub-id-type="publisher-id">1741-7015-3-14</article-id><article-id pub-id-type="doi">10.1186/1741-7015-3-14</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Suicide attempts in clinical trials with paroxetine randomised against placebo</article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>Aursnes</surname><given-names>Ivar</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>i.a.aursnes@medisin.uio.no</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Tvete</surname><given-names>Ingunn Fride</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>ift@math.uio.no</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Gaasemyr</surname><given-names>Jorund</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>gaasemyr@math.uio.no</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Natvig</surname><given-names>Bent</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>bent@math.uio.no</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Pharmacotherapeutics, University of Oslo, Oslo, Norway</aff><aff id="I2"><label>2</label>Department of Mathematics, University of Oslo, Oslo, Norway</aff><pub-date pub-type="collection"><year>2005</year></pub-date><pub-date pub-type="epub"><day>22</day><month>8</month><year>2005</year></pub-date><volume>3</volume><fpage>14</fpage><lpage>14</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1741-7015/3/14"></ext-link><history><date date-type="received"><day>8</day><month>3</month><year>2005</year></date><date date-type="accepted"><day>22</day><month>8</month><year>2005</year></date></history><permissions><copyright-statement>Copyright © 2005 Aursnes et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2005</copyright-year><copyright-holder>Aursnes et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"></ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><sec><title><offsets xml_i="3066" xml_f="3076" txt_i="11" txt_f="21">Background</offsets></title><p><offsets xml_i="3087" xml_f="3406" txt_i="22" txt_f="341">Inclusion of unpublished data on the effects of antidepressants on children has suggested unfavourable risk-benefit profiles for some of the drugs. Recent meta-analyses of studies on adults have indicated similar effects. We obtained unpublished data for paroxetine that have so far not been included in these analyses.</offsets></p></sec><sec sec-type="methods"><title><offsets xml_i="3447" xml_f="3454" txt_i="343" txt_f="350">Methods</offsets></title><p><offsets xml_i="3465" xml_f="3784" txt_i="351" txt_f="670">The documentation for drug registration contained 16 studies in which paroxetine had been randomised against placebo. We registered the number of suicides, suicide attempts and ideation. We corrected for duration of medication and placebo treatment and used a standard Bayesian statistical approach with varying priors.</offsets></p></sec><sec><title><offsets xml_i="3806" xml_f="3813" txt_i="672" txt_f="679">Results</offsets></title><p><offsets xml_i="3824" xml_f="4103" txt_i="680" txt_f="959">There were 7 suicide attempts in patients on the drug and 1 in a patient on placebo. We found that the probability of increased intensity of suicide attempts per year in adults taking paroxetine was 0.90 with a "pessimistic" prior, and somewhat less with two more neutral priors.</offsets></p></sec><sec><title><offsets xml_i="4125" xml_f="4135" txt_i="961" txt_f="971">Conclusion</offsets></title><p><offsets xml_i="4146" xml_f="4382" txt_i="972" txt_f="1208">Our findings support the results of recent meta-analyses. Patients and doctors should be warned that the increased suicidal activity observed in children and adolescents taking certain antidepressant drugs may also be present in adults.</offsets></p></sec></abstract></article-meta></front><body><sec><title><offsets xml_i="4444" xml_f="4454" txt_i="1217" txt_f="1227">Background</offsets></title><p><offsets xml_i="4465" xml_f="4615" txt_i="1228" txt_f="1378">The debate about whether the use of antidepressant drugs increases suicidal activity has recently been sharpened after more than 10 years of turmoil [</offsets><xref ref-type="bibr" rid="B1"><offsets xml_i="4646" xml_f="4647" txt_i="1378" txt_f="1379">1</offsets></xref><offsets xml_i="4654" xml_f="4722" txt_i="1379" txt_f="1447">]. Conclusions concerning children and adolescents have been drawn [</offsets><xref ref-type="bibr" rid="B2"><offsets xml_i="4753" xml_f="4754" txt_i="1447" txt_f="1448">2</offsets></xref><offsets xml_i="4761" xml_f="4961" txt_i="1448" txt_f="1648">]. Inclusion of unpublished data suggested unfavourable risk-benefit profiles for some of the drugs. For adults, industry points to the absence of data refuting the null hypothesis (no such increase).</offsets></p><p><offsets xml_i="4968" xml_f="4984" txt_i="1649" txt_f="1665">In a February 19</offsets><sup><offsets xml_i="4989" xml_f="4992" txt_i="1665" txt_f="1668">th </offsets></sup><offsets xml_i="4998" xml_f="5013" txt_i="1668" txt_f="1683">BMJ editorial [</offsets><xref ref-type="bibr" rid="B3"><offsets xml_i="5044" xml_f="5045" txt_i="1683" txt_f="1684">3</offsets></xref><offsets xml_i="5052" xml_f="5136" txt_i="1684" txt_f="1768">] accompanying two meta-analyses of suicidal activities in adult patients on SSRIs [</offsets><xref ref-type="bibr" rid="B4"><offsets xml_i="5167" xml_f="5168" txt_i="1768" txt_f="1769">4</offsets></xref><offsets xml_i="5175" xml_f="5176" txt_i="1769" txt_f="1770">,</offsets><xref ref-type="bibr" rid="B5"><offsets xml_i="5207" xml_f="5208" txt_i="1770" txt_f="1771">5</offsets></xref><offsets xml_i="5215" xml_f="5736" txt_i="1771" txt_f="2292">], the authors failed to convey the unanimous conclusion in the reviewed studies of an increased risk of suicidal attempts. Admittedly, one of the analyses only touched statistical significance, but that might have been due to the withholding of data by the manufacturer of one of the drugs. We have had access to some of those missing data. Recently we were given the opportunity to review the clinical data on paroxetine as presented to the world's drug regulatory agencies in 1989. One of the published meta-analyses [</offsets><xref ref-type="bibr" rid="B4"><offsets xml_i="5767" xml_f="5768" txt_i="2292" txt_f="2293">4</offsets></xref><offsets xml_i="5775" xml_f="6077" txt_i="2293" txt_f="2595">] contained summaries of the documentation provided by the marketing authorization holders to the MHRA, which did not distinguish between suicidal attempt and suicidal ideation for paroxetine. We studied the primary data and even the individual case descriptions when available. Another meta-analysis [</offsets><xref ref-type="bibr" rid="B5"><offsets xml_i="6108" xml_f="6109" txt_i="2595" txt_f="2596">5</offsets></xref><offsets xml_i="6116" xml_f="6571" txt_i="2596" txt_f="3051">] reported published data only, whereas most of our data were from unpublished studies. Moreover, as opposed to the BMJ authors, we have based our statistical analysis on comparing intensities of suicide attempts per year in drug and placebo groups, taking the exposure time of the patients properly into account. We now present our findings and estimate the degree of support for the idea of an increased intensity per year of suicide attempts in adults.</offsets></p></sec><sec sec-type="methods"><title><offsets xml_i="6612" xml_f="6619" txt_i="3053" txt_f="3060">Methods</offsets></title><p><offsets xml_i="6630" xml_f="7480" txt_i="3061" txt_f="3911">We included only double blind, parallel design studies with patients (all adults) randomised to either paroxetine or placebo. Altogether 16 studies met these criteria (references 79 to 93 and 95 in the Expert Report), containing respectively 916 and 550 paroxetine and placebo treated patients. The study period was in most instances 6 weeks. One important exception was a study (reference 91) with a preponderance of paroxetine use over placebo and lasting for 17 weeks. Patients were excluded from the studies after a suicide-related event. Taking this censoring into account, paroxetine treatment made up 190.7 patient years altogether and placebo 73.3 patient years. Suicide-related events could be found in tables in the Expert Report, in the adverse reactions section in the individual study reports, and in the individual patient descriptions.</offsets></p><p><offsets xml_i="7487" xml_f="7495" txt_i="3912" txt_f="3920">We let θ</offsets><sub><offsets xml_i="7500" xml_f="7502" txt_i="3920" txt_f="3922">p </offsets></sub><offsets xml_i="7508" xml_f="7581" txt_i="3922" txt_f="3995">be the intensity per year of a suicide attempt in the placebo group and θ</offsets><sub><offsets xml_i="7586" xml_f="7588" txt_i="3995" txt_f="3997">d </offsets></sub><offsets xml_i="7594" xml_f="7694" txt_i="3997" txt_f="4097">the intensity per year in the drug group, for a random patient in the 16 studies; correspondingly, X</offsets><sub><offsets xml_i="7699" xml_f="7701" txt_i="4097" txt_f="4099">p </offsets></sub><offsets xml_i="7707" xml_f="7712" txt_i="4099" txt_f="4104">and X</offsets><sub><offsets xml_i="7717" xml_f="7719" txt_i="4104" txt_f="4106">d </offsets></sub><offsets xml_i="7725" xml_f="7942" txt_i="4106" txt_f="4323">represent the total numbers of suicide attempts. We can have at most one suicide attempt for each patient. Taking this censoring into account, we denoted the corresponding patient years in the 16 studies combined by m</offsets><sub><offsets xml_i="7947" xml_f="7949" txt_i="4323" txt_f="4325">p </offsets></sub><offsets xml_i="7955" xml_f="7960" txt_i="4325" txt_f="4330">and m</offsets><sub><offsets xml_i="7965" xml_f="7966" txt_i="4330" txt_f="4331">d</offsets></sub><offsets xml_i="7972" xml_f="8146" txt_i="4331" txt_f="4505">. In addition, patients in both the placebo and drug groups are supposed to behave in a similar manner. It then follows that the likelihood of the experiment corresponds to X</offsets><sub><offsets xml_i="8151" xml_f="8153" txt_i="4505" txt_f="4507">p </offsets></sub><offsets xml_i="8159" xml_f="8164" txt_i="4507" txt_f="4512">and X</offsets><sub><offsets xml_i="8169" xml_f="8171" txt_i="4512" txt_f="4514">d </offsets></sub><offsets xml_i="8177" xml_f="8237" txt_i="4514" txt_f="4574">having Poisson distributions respectively with parameters (m</offsets><sub><offsets xml_i="8242" xml_f="8243" txt_i="4574" txt_f="4575">p</offsets></sub><offsets xml_i="8249" xml_f="8250" txt_i="4575" txt_f="4576">θ</offsets><sub><offsets xml_i="8255" xml_f="8256" txt_i="4576" txt_f="4577">p</offsets></sub><offsets xml_i="8262" xml_f="8270" txt_i="4577" txt_f="4585">) and (m</offsets><sub><offsets xml_i="8275" xml_f="8277" txt_i="4585" txt_f="4587">d </offsets></sub><offsets xml_i="8283" xml_f="8284" txt_i="4587" txt_f="4588">θ</offsets><sub><offsets xml_i="8289" xml_f="8290" txt_i="4588" txt_f="4589">d</offsets></sub><offsets xml_i="8296" xml_f="8436" txt_i="4589" txt_f="4729">). In addition, we assume that the two variables were conditionally independent given the parameters. The corresponding observed data are (x</offsets><sub><offsets xml_i="8441" xml_f="8444" txt_i="4729" txt_f="4732">p, </offsets></sub><offsets xml_i="8450" xml_f="8451" txt_i="4732" txt_f="4733">m</offsets><sub><offsets xml_i="8456" xml_f="8457" txt_i="4733" txt_f="4734">p</offsets></sub><offsets xml_i="8463" xml_f="8471" txt_i="4734" txt_f="4742">) and (x</offsets><sub><offsets xml_i="8476" xml_f="8479" txt_i="4742" txt_f="4745">d, </offsets></sub><offsets xml_i="8485" xml_f="8486" txt_i="4745" txt_f="4746">m</offsets><sub><offsets xml_i="8491" xml_f="8492" txt_i="4746" txt_f="4747">d</offsets></sub><offsets xml_i="8498" xml_f="8543" txt_i="4747" txt_f="4792">), and the prior information is denoted by (x</offsets><sup><offsets xml_i="8548" xml_f="8549" txt_i="4792" txt_f="4793">o</offsets></sup><sub><offsets xml_i="8560" xml_f="8561" txt_i="4793" txt_f="4794">p</offsets></sub><offsets xml_i="8567" xml_f="8570" txt_i="4794" txt_f="4797">, m</offsets><sup><offsets xml_i="8575" xml_f="8576" txt_i="4797" txt_f="4798">o</offsets></sup><sub><offsets xml_i="8587" xml_f="8588" txt_i="4798" txt_f="4799">p</offsets></sub><offsets xml_i="8594" xml_f="8602" txt_i="4799" txt_f="4807">) and (x</offsets><sup><offsets xml_i="8607" xml_f="8608" txt_i="4807" txt_f="4808">o</offsets></sup><sub><offsets xml_i="8619" xml_f="8620" txt_i="4808" txt_f="4809">d</offsets></sub><offsets xml_i="8626" xml_f="8629" txt_i="4809" txt_f="4812">, m</offsets><sup><offsets xml_i="8634" xml_f="8635" txt_i="4812" txt_f="4813">o</offsets></sup><sub><offsets xml_i="8646" xml_f="8647" txt_i="4813" txt_f="4814">d</offsets></sub><offsets xml_i="8653" xml_f="8655" txt_i="4814" txt_f="4816">).</offsets></p><p><offsets xml_i="8662" xml_f="8747" txt_i="4817" txt_f="4902">The Bayesian approach is based on the construction of probability distributions for θ</offsets><sub><offsets xml_i="8752" xml_f="8754" txt_i="4902" txt_f="4904">p </offsets></sub><offsets xml_i="8760" xml_f="8765" txt_i="4904" txt_f="4909">and θ</offsets><sub><offsets xml_i="8770" xml_f="8772" txt_i="4909" txt_f="4911">d </offsets></sub><offsets xml_i="8778" xml_f="9342" txt_i="4911" txt_f="5475">. This does not mean that these parameters are to be interpreted as random variables, but our knowledge of the parameters is uncertain and we describe this uncertainty with the help of probability distributions. Probability distributions describing our initial uncertainty are called prior distributions (that is, before real data are collected). When the real data are taken into account, the prior distributions are updated by Bayes' formula to posterior distributions. An excellent introduction to Bayesian methods in medicine is given by Spiegelhalter et al. [</offsets><xref ref-type="bibr" rid="B6"><offsets xml_i="9373" xml_f="9374" txt_i="5475" txt_f="5476">6</offsets></xref><offsets xml_i="9381" xml_f="9383" txt_i="5476" txt_f="5478">].</offsets></p><p><offsets xml_i="9390" xml_f="9433" txt_i="5479" txt_f="5522">We assume that the prior distribution for θ</offsets><sub><offsets xml_i="9438" xml_f="9440" txt_i="5522" txt_f="5524">p </offsets></sub><offsets xml_i="9446" xml_f="9473" txt_i="5524" txt_f="5551">is gamma, with parameters x</offsets><sup><offsets xml_i="9478" xml_f="9479" txt_i="5551" txt_f="5552">o</offsets></sup><sub><offsets xml_i="9490" xml_f="9492" txt_i="5552" txt_f="5554">p </offsets></sub><offsets xml_i="9498" xml_f="9503" txt_i="5554" txt_f="5559">and m</offsets><sup><offsets xml_i="9508" xml_f="9509" txt_i="5559" txt_f="5560">o</offsets></sup><sub><offsets xml_i="9520" xml_f="9521" txt_i="5560" txt_f="5561">p</offsets></sub><offsets xml_i="9527" xml_f="9552" txt_i="5561" txt_f="5586">, while correspondingly θ</offsets><sub><offsets xml_i="9557" xml_f="9559" txt_i="5586" txt_f="5588">d </offsets></sub><offsets xml_i="9565" xml_f="9585" txt_i="5588" txt_f="5608">has the parameters x</offsets><sup><offsets xml_i="9590" xml_f="9591" txt_i="5608" txt_f="5609">o</offsets></sup><sub><offsets xml_i="9602" xml_f="9604" txt_i="5609" txt_f="5611">d </offsets></sub><offsets xml_i="9610" xml_f="9615" txt_i="5611" txt_f="5616">and m</offsets><sup><offsets xml_i="9620" xml_f="9621" txt_i="5616" txt_f="5617">o</offsets></sup><sub><offsets xml_i="9632" xml_f="9634" txt_i="5617" txt_f="5619">d </offsets></sub><offsets xml_i="9640" xml_f="9704" txt_i="5619" txt_f="5683">and is assumed to be independent of the prior distribution for θ</offsets><sub><offsets xml_i="9709" xml_f="9710" txt_i="5683" txt_f="5684">p</offsets></sub><offsets xml_i="9716" xml_f="9787" txt_i="5684" txt_f="5755">. Hence, standard Bayesian theory gives the posterior distribution of θ</offsets><sub><offsets xml_i="9792" xml_f="9794" txt_i="5755" txt_f="5757">p </offsets></sub><offsets xml_i="9800" xml_f="9827" txt_i="5757" txt_f="5784">as gamma, with parameters x</offsets><sup><offsets xml_i="9832" xml_f="9833" txt_i="5784" txt_f="5785">o</offsets></sup><sub><offsets xml_i="9844" xml_f="9846" txt_i="5785" txt_f="5787">p </offsets></sub><offsets xml_i="9852" xml_f="9855" txt_i="5787" txt_f="5790">+ x</offsets><sub><offsets xml_i="9860" xml_f="9862" txt_i="5790" txt_f="5792">p </offsets></sub><offsets xml_i="9868" xml_f="9873" txt_i="5792" txt_f="5797">and m</offsets><sup><offsets xml_i="9878" xml_f="9879" txt_i="5797" txt_f="5798">o</offsets></sup><sub><offsets xml_i="9890" xml_f="9892" txt_i="5798" txt_f="5800">p </offsets></sub><offsets xml_i="9898" xml_f="9901" txt_i="5800" txt_f="5803">+ m</offsets><sub><offsets xml_i="9906" xml_f="9909" txt_i="5803" txt_f="5806">p, </offsets></sub><offsets xml_i="9915" xml_f="9922" txt_i="5806" txt_f="5813">while θ</offsets><sub><offsets xml_i="9927" xml_f="9929" txt_i="5813" txt_f="5815">d </offsets></sub><offsets xml_i="9935" xml_f="9961" txt_i="5815" txt_f="5841">will have the parameters x</offsets><sup><offsets xml_i="9966" xml_f="9967" txt_i="5841" txt_f="5842">o</offsets></sup><sub><offsets xml_i="9978" xml_f="9980" txt_i="5842" txt_f="5844">d </offsets></sub><offsets xml_i="9986" xml_f="9989" txt_i="5844" txt_f="5847">+ x</offsets><sub><offsets xml_i="9994" xml_f="9996" txt_i="5847" txt_f="5849">d </offsets></sub><offsets xml_i="10002" xml_f="10007" txt_i="5849" txt_f="5854">and m</offsets><sup><offsets xml_i="10012" xml_f="10013" txt_i="5854" txt_f="5855">o</offsets></sup><sub><offsets xml_i="10024" xml_f="10026" txt_i="5855" txt_f="5857">d </offsets></sub><offsets xml_i="10032" xml_f="10035" txt_i="5857" txt_f="5860">+ m</offsets><sub><offsets xml_i="10040" xml_f="10041" txt_i="5860" txt_f="5861">d</offsets></sub><offsets xml_i="10047" xml_f="10107" txt_i="5861" txt_f="5921">. We performed simulations by making 80000 random draws of θ</offsets><sub><offsets xml_i="10112" xml_f="10114" txt_i="5921" txt_f="5923">d </offsets></sub><offsets xml_i="10120" xml_f="10125" txt_i="5923" txt_f="5928">and θ</offsets><sub><offsets xml_i="10130" xml_f="10132" txt_i="5928" txt_f="5930">p </offsets></sub><offsets xml_i="10138" xml_f="10231" txt_i="5930" txt_f="6023">from their independent gamma posterior distributions, computed the logarithms of the ratios θ</offsets><sub><offsets xml_i="10236" xml_f="10237" txt_i="6023" txt_f="6024">d</offsets></sub><offsets xml_i="10243" xml_f="10245" txt_i="6024" txt_f="6026">/θ</offsets><sub><offsets xml_i="10250" xml_f="10253" txt_i="6026" txt_f="6029">p, </offsets></sub><offsets xml_i="10259" xml_f="10490" txt_i="6029" txt_f="6260">and constructed diagrams by applying a standard density estimation technique to these logarithms. (The logarithm was introduced to avoid an unwelcome feature of the density estimation method.) Note that the logarithm of the ratio θ</offsets><sub><offsets xml_i="10495" xml_f="10496" txt_i="6260" txt_f="6261">d</offsets></sub><offsets xml_i="10502" xml_f="10504" txt_i="6261" txt_f="6263">/θ</offsets><sub><offsets xml_i="10509" xml_f="10511" txt_i="6263" txt_f="6265">p </offsets></sub><offsets xml_i="10517" xml_f="10548" txt_i="6265" txt_f="6296">is greater than zero whenever θ</offsets><sub><offsets xml_i="10553" xml_f="10555" txt_i="6296" txt_f="6298">d </offsets></sub><offsets xml_i="10561" xml_f="10578" txt_i="6298" txt_f="6315">is greater than θ</offsets><sub><offsets xml_i="10583" xml_f="10584" txt_i="6315" txt_f="6316">p</offsets></sub><offsets xml_i="10590" xml_f="10893" txt_i="6316" txt_f="6619">. Hence, we calculated the probabilities that medication with paroxetine is associated with an increased intensity of a suicide attempt per year as the proportions of logarithmic ratios greater than zero in the samples. This corresponds to areas below the densities to the right of zero in the diagrams.</offsets></p><p><offsets xml_i="10900" xml_f="10975" txt_i="6620" txt_f="6695">The grounds for a pessimistic prior have been given by Healy and Whitaker [</offsets><xref ref-type="bibr" rid="B7"><offsets xml_i="11006" xml_f="11007" txt_i="6695" txt_f="6696">7</offsets></xref><offsets xml_i="11014" xml_f="11433" txt_i="6696" txt_f="7115">] who, relating the occurrence of suicidal activities to the use of antidepressant drugs, estimated an odds ratio of 2.4 from evidence given in clinical trials, epidemiological observations and case histories. The clinical trial data they used included, but were not restricted to, studies with the active drugs randomised against placebo. Mathematically, we chose to express this view as equivalent to observing two (x</offsets><sup><offsets xml_i="11438" xml_f="11439" txt_i="7115" txt_f="7116">o</offsets></sup><sub><offsets xml_i="11450" xml_f="11451" txt_i="7116" txt_f="7117">d</offsets></sub><offsets xml_i="11457" xml_f="11494" txt_i="7117" txt_f="7154">) events with paroxetine during 50 (m</offsets><sup><offsets xml_i="11499" xml_f="11500" txt_i="7154" txt_f="7155">o</offsets></sup><sub><offsets xml_i="11511" xml_f="11512" txt_i="7155" txt_f="7156">d</offsets></sub><offsets xml_i="11518" xml_f="11544" txt_i="7156" txt_f="7182">) patient years and one (x</offsets><sup><offsets xml_i="11549" xml_f="11550" txt_i="7182" txt_f="7183">o</offsets></sup><sub><offsets xml_i="11561" xml_f="11562" txt_i="7183" txt_f="7184">p</offsets></sub><offsets xml_i="11568" xml_f="11595" txt_i="7184" txt_f="7211">) with placebo during 50 (m</offsets><sup><offsets xml_i="11600" xml_f="11601" txt_i="7211" txt_f="7212">o</offsets></sup><sub><offsets xml_i="11612" xml_f="11613" txt_i="7212" txt_f="7213">p</offsets></sub><offsets xml_i="11619" xml_f="11824" txt_i="7213" txt_f="7418">) patient years, adding up to 3 attempts per 100 patient years, which is similar to our observed average value for paroxetine and placebo taken together. We based the calculations on a total of only 100 (m</offsets><sup><offsets xml_i="11829" xml_f="11830" txt_i="7418" txt_f="7419">o</offsets></sup><sub><offsets xml_i="11841" xml_f="11843" txt_i="7419" txt_f="7421">d </offsets></sub><offsets xml_i="11849" xml_f="11852" txt_i="7421" txt_f="7424">+ m</offsets><sup><offsets xml_i="11857" xml_f="11858" txt_i="7424" txt_f="7425">o</offsets></sup><sub><offsets xml_i="11869" xml_f="11870" txt_i="7425" txt_f="7426">p</offsets></sub><offsets xml_i="11876" xml_f="11924" txt_i="7426" txt_f="7474">) patient years in the prior, compared to 264 (m</offsets><sub><offsets xml_i="11929" xml_f="11931" txt_i="7474" txt_f="7476">d </offsets></sub><offsets xml_i="11937" xml_f="11940" txt_i="7476" txt_f="7479">+ m</offsets><sub><offsets xml_i="11945" xml_f="11946" txt_i="7479" txt_f="7480">p</offsets></sub><offsets xml_i="11952" xml_f="12167" txt_i="7480" txt_f="7695">) patient years in the real data, in order to increase the importance of the real data over the prior information. The slightly optimistic and slightly pessimistic priors represent respectively a paper by Lapierre [</offsets><xref ref-type="bibr" rid="B8"><offsets xml_i="12198" xml_f="12199" txt_i="7695" txt_f="7696">8</offsets></xref><offsets xml_i="12206" xml_f="12341" txt_i="7696" txt_f="7831">] (appearing in tandem with Healy and Whitaker) and the article that reported suicidal ideation in children medicated with paroxetine [</offsets><xref ref-type="bibr" rid="B2"><offsets xml_i="12372" xml_f="12373" txt_i="7831" txt_f="7832">2</offsets></xref><offsets xml_i="12380" xml_f="12810" txt_i="7832" txt_f="8262">]. The former author took the attitude that, if anything, there were slight signs of reduced suicidal activity connected with antidepressants, whereas the latter authors left the reader with the assumption that the observed increased suicidal ideation in children must somehow be reflected in adults. We assigned the numbers of suicidal patients on paroxetine and placebo per 50 patient years to be respectively 1.35 and 1.65 and </offsets><italic><offsets xml_i="12818" xml_f="12828" txt_i="8262" txt_f="8272">vice versa</offsets></italic><offsets xml_i="12837" xml_f="12838" txt_i="8272" txt_f="8273">.</offsets></p></sec><sec><title><offsets xml_i="12860" xml_f="12867" txt_i="8275" txt_f="8282">Results</offsets></title><p><offsets xml_i="12878" xml_f="13003" txt_i="8283" txt_f="8408">There were no suicides in the 16 studies with paroxetine randomised against placebo. Suicidal activities are listed in table </offsets><xref ref-type="table" rid="T1"><offsets xml_i="13035" xml_f="13036" txt_i="8408" txt_f="8409">1</offsets></xref><offsets xml_i="13043" xml_f="13301" txt_i="8409" txt_f="8667">. Summarising the suicide attempts, there are seven among the patients on paroxetine and one among the patients on placebo. (One event tabulated in the Expert Report as occurring with placebo did in fact happen during the run-in period before randomisation.)</offsets></p><table-wrap position="float" id="T1"><label><offsets xml_i="13349" xml_f="13356" txt_i="8668" txt_f="8675">Table 1</offsets></label><caption><p><offsets xml_i="13376" xml_f="13580" txt_i="8675" txt_f="8879">Suicide attempts and ideation in randomised clinical trials with paroxetine against placebo. Extracted from "APPLICATION FOR MARKETING AUTHORIZATION: SEROXAT" 1989. * Referring to list in Part I, Volume 3</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><bold><offsets xml_i="13665" xml_f="13694" txt_i="8880" txt_f="8909">Patient identification number</offsets></bold></td><td align="left"><bold><offsets xml_i="13729" xml_f="13752" txt_i="8910" txt_f="8933">Study reference number*</offsets></bold></td><td align="center"><bold><offsets xml_i="13789" xml_f="13805" txt_i="8934" txt_f="8950">Suicidal attempt</offsets></bold></td><td align="center"><bold><offsets xml_i="13842" xml_f="13859" txt_i="8951" txt_f="8968">Suicidal ideation</offsets></bold></td><td align="left"><bold><offsets xml_i="13894" xml_f="13904" txt_i="8969" txt_f="8979">Medication</offsets></bold></td><td align="center"><bold><offsets xml_i="13941" xml_f="13950" txt_i="8980" txt_f="8989">Tabulated</offsets></bold></td><td align="left"><bold><offsets xml_i="13985" xml_f="14007" txt_i="8990" txt_f="9012">Individually described</offsets></bold></td></tr></thead><tbody><tr><td align="left"><offsets xml_i="14060" xml_f="14069" txt_i="9013" txt_f="9022">02 01 009</offsets></td><td align="center"><offsets xml_i="14093" xml_f="14095" txt_i="9023" txt_f="9025">79</offsets></td><td align="center"><offsets xml_i="14119" xml_f="14120" txt_i="9026" txt_f="9027">X</offsets></td><td></td><td align="left"><offsets xml_i="14151" xml_f="14158" txt_i="9029" txt_f="9036">Placebo</offsets></td><td align="center"><offsets xml_i="14182" xml_f="14185" txt_i="9037" txt_f="9040">Yes</offsets></td><td align="center"><offsets xml_i="14209" xml_f="14212" txt_i="9041" txt_f="9044">Yes</offsets></td></tr><tr><td align="left"><offsets xml_i="14243" xml_f="14252" txt_i="9045" txt_f="9054">02 04 089</offsets></td><td align="center"><offsets xml_i="14276" xml_f="14278" txt_i="9055" txt_f="9057">82</offsets></td><td align="center"><offsets xml_i="14302" xml_f="14303" txt_i="9058" txt_f="9059">X</offsets></td><td></td><td align="left"><offsets xml_i="14334" xml_f="14344" txt_i="9061" txt_f="9071">Paroxetine</offsets></td><td align="center"><offsets xml_i="14368" xml_f="14371" txt_i="9072" txt_f="9075">Yes</offsets></td><td align="center"><offsets xml_i="14395" xml_f="14398" txt_i="9076" txt_f="9079">Yes</offsets></td></tr><tr><td align="left"><offsets xml_i="14429" xml_f="14439" txt_i="9080" txt_f="9090">03 002 034</offsets></td><td align="center"><offsets xml_i="14463" xml_f="14465" txt_i="9091" txt_f="9093">84</offsets></td><td></td><td align="center"><offsets xml_i="14498" xml_f="14499" txt_i="9095" txt_f="9096">X</offsets></td><td align="left"><offsets xml_i="14521" xml_f="14528" txt_i="9097" txt_f="9104">Placebo</offsets></td><td align="center"><offsets xml_i="14552" xml_f="14554" txt_i="9105" txt_f="9107">No</offsets></td><td align="center"><offsets xml_i="14578" xml_f="14581" txt_i="9108" txt_f="9111">Yes</offsets></td></tr><tr><td align="left"><offsets xml_i="14612" xml_f="14621" txt_i="9112" txt_f="9121">04 02 056</offsets></td><td align="center"><offsets xml_i="14645" xml_f="14647" txt_i="9122" txt_f="9124">84</offsets></td><td align="center"><offsets xml_i="14671" xml_f="14672" txt_i="9125" txt_f="9126">X</offsets></td><td></td><td align="left"><offsets xml_i="14703" xml_f="14713" txt_i="9128" txt_f="9138">Paroxetine</offsets></td><td align="center"><offsets xml_i="14737" xml_f="14740" txt_i="9139" txt_f="9142">Yes</offsets></td><td align="center"><offsets xml_i="14764" xml_f="14767" txt_i="9143" txt_f="9146">Yes</offsets></td></tr><tr><td align="left"><offsets xml_i="14798" xml_f="14806" txt_i="9147" txt_f="9155">1 09 021</offsets></td><td align="center"><offsets xml_i="14830" xml_f="14832" txt_i="9156" txt_f="9158">90</offsets></td><td align="center"><offsets xml_i="14856" xml_f="14857" txt_i="9159" txt_f="9160">X</offsets></td><td></td><td align="left"><offsets xml_i="14888" xml_f="14895" txt_i="9162" txt_f="9169">Washout</offsets></td><td align="center"><offsets xml_i="14919" xml_f="14922" txt_i="9170" txt_f="9173">Yes</offsets></td><td align="center"><offsets xml_i="14946" xml_f="14949" txt_i="9174" txt_f="9177">Yes</offsets></td></tr><tr><td align="left"><offsets xml_i="14980" xml_f="14990" txt_i="9178" txt_f="9188">09 01A 005</offsets></td><td align="center"><offsets xml_i="15014" xml_f="15016" txt_i="9189" txt_f="9191">91</offsets></td><td align="center"><offsets xml_i="15040" xml_f="15041" txt_i="9192" txt_f="9193">X</offsets></td><td></td><td align="left"><offsets xml_i="15072" xml_f="15082" txt_i="9195" txt_f="9205">Paroxetine</offsets></td><td align="center"><offsets xml_i="15106" xml_f="15109" txt_i="9206" txt_f="9209">Yes</offsets></td><td align="center"><offsets xml_i="15133" xml_f="15136" txt_i="9210" txt_f="9213">Yes</offsets></td></tr><tr><td align="left"><offsets xml_i="15167" xml_f="15177" txt_i="9214" txt_f="9224">09-01A-006</offsets></td><td align="center"><offsets xml_i="15201" xml_f="15203" txt_i="9225" txt_f="9227">91</offsets></td><td></td><td align="center"><offsets xml_i="15236" xml_f="15237" txt_i="9229" txt_f="9230">X</offsets></td><td align="left"><offsets xml_i="15259" xml_f="15269" txt_i="9231" txt_f="9241">Paroxetine</offsets></td><td align="center"><offsets xml_i="15293" xml_f="15295" txt_i="9242" txt_f="9244">No</offsets></td><td align="center"><offsets xml_i="15319" xml_f="15322" txt_i="9245" txt_f="9248">Yes</offsets></td></tr><tr><td align="left"><offsets xml_i="15353" xml_f="15363" txt_i="9249" txt_f="9259">09 01E 260</offsets></td><td align="center"><offsets xml_i="15387" xml_f="15389" txt_i="9260" txt_f="9262">91</offsets></td><td align="center"><offsets xml_i="15413" xml_f="15414" txt_i="9263" txt_f="9264">X</offsets></td><td></td><td align="left"><offsets xml_i="15445" xml_f="15455" txt_i="9266" txt_f="9276">Paroxetine</offsets></td><td align="center"><offsets xml_i="15479" xml_f="15482" txt_i="9277" txt_f="9280">Yes</offsets></td><td align="center"><offsets xml_i="15506" xml_f="15508" txt_i="9281" txt_f="9283">No</offsets></td></tr><tr><td align="left"><offsets xml_i="15539" xml_f="15549" txt_i="9284" txt_f="9294">09 01J 573</offsets></td><td align="center"><offsets xml_i="15573" xml_f="15575" txt_i="9295" txt_f="9297">91</offsets></td><td align="center"><offsets xml_i="15599" xml_f="15600" txt_i="9298" txt_f="9299">X</offsets></td><td></td><td align="left"><offsets xml_i="15631" xml_f="15641" txt_i="9301" txt_f="9311">Paroxetine</offsets></td><td align="center"><offsets xml_i="15665" xml_f="15668" txt_i="9312" txt_f="9315">Yes</offsets></td><td align="center"><offsets xml_i="15692" xml_f="15695" txt_i="9316" txt_f="9319">Yes</offsets></td></tr><tr><td align="left"><offsets xml_i="15726" xml_f="15735" txt_i="9320" txt_f="9329">09-OU-620</offsets></td><td align="center"><offsets xml_i="15759" xml_f="15761" txt_i="9330" txt_f="9332">91</offsets></td><td></td><td align="center"><offsets xml_i="15794" xml_f="15795" txt_i="9334" txt_f="9335">X</offsets></td><td align="left"><offsets xml_i="15817" xml_f="15827" txt_i="9336" txt_f="9346">Paroxetine</offsets></td><td align="center"><offsets xml_i="15851" xml_f="15853" txt_i="9347" txt_f="9349">No</offsets></td><td align="center"><offsets xml_i="15877" xml_f="15880" txt_i="9350" txt_f="9353">Yes</offsets></td></tr><tr><td align="left"><offsets xml_i="15911" xml_f="15921" txt_i="9354" txt_f="9364">09-01G-405</offsets></td><td align="center"><offsets xml_i="15945" xml_f="15947" txt_i="9365" txt_f="9367">91</offsets></td><td></td><td align="center"><offsets xml_i="15980" xml_f="15981" txt_i="9369" txt_f="9370">X</offsets></td><td align="left"><offsets xml_i="16003" xml_f="16013" txt_i="9371" txt_f="9381">Paroxetine</offsets></td><td align="center"><offsets xml_i="16037" xml_f="16039" txt_i="9382" txt_f="9384">No</offsets></td><td align="center"><offsets xml_i="16063" xml_f="16066" txt_i="9385" txt_f="9388">Yes</offsets></td></tr><tr><td align="left"><offsets xml_i="16097" xml_f="16100" txt_i="9389" txt_f="9392">037</offsets></td><td align="center"><offsets xml_i="16124" xml_f="16126" txt_i="9393" txt_f="9395">93</offsets></td><td align="center"><offsets xml_i="16150" xml_f="16151" txt_i="9396" txt_f="9397">X</offsets></td><td></td><td align="left"><offsets xml_i="16182" xml_f="16192" txt_i="9399" txt_f="9409">Paroxetine</offsets></td><td align="center"><offsets xml_i="16216" xml_f="16218" txt_i="9410" txt_f="9412">No</offsets></td><td align="center"><offsets xml_i="16242" xml_f="16245" txt_i="9413" txt_f="9416">Yes</offsets></td></tr><tr><td align="left"><offsets xml_i="16276" xml_f="16286" txt_i="9417" txt_f="9427">07 01A 001</offsets></td><td align="center"><offsets xml_i="16310" xml_f="16312" txt_i="9428" txt_f="9430">95</offsets></td><td align="center"><offsets xml_i="16336" xml_f="16337" txt_i="9431" txt_f="9432">X</offsets></td><td></td><td align="left"><offsets xml_i="16368" xml_f="16378" txt_i="9434" txt_f="9444">Paroxetine</offsets></td><td align="center"><offsets xml_i="16402" xml_f="16405" txt_i="9445" txt_f="9448">Yes</offsets></td><td align="center"><offsets xml_i="16429" xml_f="16432" txt_i="9449" txt_f="9452">Yes</offsets></td></tr></tbody></table></table-wrap><p><offsets xml_i="16474" xml_f="16535" txt_i="9453" txt_f="9514">The three prior distributions of the logarithm of the ratio θ</offsets><sub><offsets xml_i="16540" xml_f="16541" txt_i="9514" txt_f="9515">d</offsets></sub><offsets xml_i="16547" xml_f="16549" txt_i="9515" txt_f="9517">/θ</offsets><sub><offsets xml_i="16554" xml_f="16556" txt_i="9517" txt_f="9519">p </offsets></sub><offsets xml_i="16562" xml_f="16582" txt_i="9519" txt_f="9539">are shown in figure </offsets><xref ref-type="fig" rid="F1"><offsets xml_i="16612" xml_f="16613" txt_i="9539" txt_f="9540">1</offsets></xref><offsets xml_i="16620" xml_f="16688" txt_i="9540" txt_f="9608">, and the corresponding posterior distributions are shown in figure </offsets><xref ref-type="fig" rid="F2"><offsets xml_i="16718" xml_f="16719" txt_i="9608" txt_f="9609">2</offsets></xref><offsets xml_i="16726" xml_f="16904" txt_i="9609" txt_f="9787">. The probability that medication with paroxetine is associated with an increased intensity per year of a suicide attempt is 0.90 with the pessimistic prior (Healy and Whitaker [</offsets><xref ref-type="bibr" rid="B7"><offsets xml_i="16935" xml_f="16936" txt_i="9787" txt_f="9788">7</offsets></xref><offsets xml_i="16943" xml_f="16967" txt_i="9788" txt_f="9812">]), and 0.79 (Lapierre [</offsets><xref ref-type="bibr" rid="B8"><offsets xml_i="16998" xml_f="16999" txt_i="9812" txt_f="9813">8</offsets></xref><offsets xml_i="17006" xml_f="17031" txt_i="9813" txt_f="9838">]) and 0.85 (Whittington </offsets><italic><offsets xml_i="17039" xml_f="17046" txt_i="9838" txt_f="9845">et al. </offsets></italic><offsets xml_i="17055" xml_f="17056" txt_i="9845" txt_f="9846">[</offsets><xref ref-type="bibr" rid="B2"><offsets xml_i="17087" xml_f="17088" txt_i="9846" txt_f="9847">2</offsets></xref><offsets xml_i="17095" xml_f="17201" txt_i="9847" txt_f="9953">]) with the two other priors. The corresponding prior probabilities were respectively 0.75, 0.42 and 0.58.</offsets></p><fig position="float" id="F1"><label><offsets xml_i="17242" xml_f="17250" txt_i="9954" txt_f="9962">Figure 1</offsets></label><caption><p><bold><offsets xml_i="17276" xml_f="17313" txt_i="9962" txt_f="9999">Prior intensity of suicidal attempt. </offsets></bold><offsets xml_i="17320" xml_f="17522" txt_i="9999" txt_f="10201">Distributions of three different prior (see text) logarithmic intensity ratios ln(θd/θp) (logarithmic intensity of a suicide attempt on drug minus logarithmic intensity of a suicide attempt on placebo).</offsets></p></caption><graphic xlink:href="1741-7015-3-14-1"></graphic></fig><fig position="float" id="F2"><label><offsets xml_i="17628" xml_f="17636" txt_i="10202" txt_f="10210">Figure 2</offsets></label><caption><p><bold><offsets xml_i="17662" xml_f="17703" txt_i="10210" txt_f="10251">Posterior intensity of suicidal attempt. </offsets></bold><offsets xml_i="17710" xml_f="17770" txt_i="10251" txt_f="10311">Distributions of posterior logarithmic intensity ratios ln(θ</offsets><sub><offsets xml_i="17775" xml_f="17776" txt_i="10311" txt_f="10312">d</offsets></sub><offsets xml_i="17782" xml_f="17784" txt_i="10312" txt_f="10314">/θ</offsets><sub><offsets xml_i="17789" xml_f="17790" txt_i="10314" txt_f="10315">p</offsets></sub><offsets xml_i="17796" xml_f="17826" txt_i="10315" txt_f="10345">) with three different priors.</offsets></p></caption><graphic xlink:href="1741-7015-3-14-2"></graphic></fig></sec><sec><title><offsets xml_i="17913" xml_f="17923" txt_i="10347" txt_f="10357">Discussion</offsets></title><p><offsets xml_i="17934" xml_f="18287" txt_i="10358" txt_f="10711">We believe that the chosen studies are similar enough to be pooled for analysis. This view is supported by the similarities of the protocols for the various studies, although the populations that were studied differed considerably. We also believe it is best to count patient years rather than patients, although claims have been made for the contrary [</offsets><xref ref-type="bibr" rid="B7"><offsets xml_i="18318" xml_f="18319" txt_i="10711" txt_f="10712">7</offsets></xref><offsets xml_i="18326" xml_f="18643" txt_i="10712" txt_f="11029">]. At least, counting patient years is a more conservative approach. Furthermore, to treat the patient as a unit and to assume binomial distributions would be inappropriate since patients have different follow-up times and hence different probabilities of suicide attempts within both the placebo and the drug groups.</offsets></p><p><offsets xml_i="18650" xml_f="18766" txt_i="11030" txt_f="11146">Another statistical approach would have been to express the prior distributions in terms of independent priors for θ</offsets><sub><offsets xml_i="18771" xml_f="18773" txt_i="11146" txt_f="11148">p </offsets></sub><offsets xml_i="18779" xml_f="18794" txt_i="11148" txt_f="11163">and the ratio θ</offsets><sub><offsets xml_i="18799" xml_f="18800" txt_i="11163" txt_f="11164">d</offsets></sub><offsets xml_i="18806" xml_f="18808" txt_i="11164" txt_f="11166">/θ</offsets><sub><offsets xml_i="18813" xml_f="18814" txt_i="11166" txt_f="11167">p</offsets></sub><offsets xml_i="18820" xml_f="18864" txt_i="11167" txt_f="11211">, with a common, relatively weak prior for θ</offsets><sub><offsets xml_i="18869" xml_f="18871" txt_i="11211" txt_f="11213">p </offsets></sub><offsets xml_i="18877" xml_f="18985" txt_i="11213" txt_f="11321">in all three formulations. This was our approach in a previous publication using basically the same method [</offsets><xref ref-type="bibr" rid="B9"><offsets xml_i="19016" xml_f="19017" txt_i="11321" txt_f="11322">9</offsets></xref><offsets xml_i="19024" xml_f="19136" txt_i="11322" txt_f="11434">]. To make things simpler and perhaps more transparent in this short paper, we have not used this approach here.</offsets></p></sec><sec><title><offsets xml_i="19158" xml_f="19168" txt_i="11436" txt_f="11446">Conclusion</offsets></title><p><offsets xml_i="19179" xml_f="19742" txt_i="11447" txt_f="12010">Although we report a small data set, by taking various priors into account the data strongly suggest that the use of SSRIs is connected with an increased intensity of suicide attempts per year. The two meta-analyses and our contribution taken together make a strong case for the conclusion, at least with a short time perspective, that adults taking antidepressants have an increased risk of suicide attempts. We also conclude that the recommendation of restrictions on the use of paroxetine for children and adolescents recently conveyed by regulatory agencies [</offsets><xref ref-type="bibr" rid="B10"><offsets xml_i="19774" xml_f="19776" txt_i="12010" txt_f="12012">10</offsets></xref><offsets xml_i="19783" xml_f="19831" txt_i="12012" txt_f="12060">] should be extended to include usage by adults.</offsets></p></sec><sec><title><offsets xml_i="19853" xml_f="19872" txt_i="12062" txt_f="12081">Competing interests</offsets></title><p><offsets xml_i="19883" xml_f="19943" txt_i="12082" txt_f="12142">The author(s) declare that they have no competing interests.</offsets></p></sec><sec><title><offsets xml_i="19965" xml_f="19987" txt_i="12144" txt_f="12166">Authors' contributions</offsets></title><p><offsets xml_i="19998" xml_f="20170" txt_i="12167" txt_f="12339">IA collected the data, presented the problem and drafted the manuscript along with BN, who suggested the statistical solution based on earlier work by the present authors [</offsets><xref ref-type="bibr" rid="B9"><offsets xml_i="20201" xml_f="20202" txt_i="12339" txt_f="12340">9</offsets></xref><offsets xml_i="20209" xml_f="20333" txt_i="12340" txt_f="12464">]; IFT did the computations and took part in the planning along with JG. All authors read and approved the final manuscript.</offsets></p></sec><sec><title><offsets xml_i="20355" xml_f="20378" txt_i="12466" txt_f="12489">Pre-publication history</offsets></title><p><offsets xml_i="20389" xml_f="20453" txt_i="12490" txt_f="12554">The pre-publication history for this paper can be accessed here:</offsets></p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1741-7015/3/14/prepub"></ext-link></p></sec></body><back><ack><sec><title>Acknowledgements</title><p>Journalist Ane Hoyem, the Norwegian Broadcasting Corporation (NRK), encouraged this investigation while researching for the medical information program "Puls".</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Breggin</surname><given-names>PR</given-names></name></person-group><article-title>Suicidality, violence and mania caused by selective serotonin reuptake inhibitors (SSRI): A review and analysis</article-title><source>International Journal of Risk and Safety in Medicine</source><year>2004</year><volume>16</volume><fpage>31</fpage><lpage>49</lpage></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Whittington</surname><given-names>CJ</given-names></name><name><surname>Kendall</surname><given-names>T</given-names></name><name><surname>Fonagy</surname><given-names>O</given-names></name><name><surname>Cottrell</surname><given-names>D</given-names></name><name><surname>Cotgrove</surname><given-names>A</given-names></name><name><surname>Boddington</surname><given-names>E</given-names></name></person-group><article-title>Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data</article-title><source>Lancet</source><year>2004</year><volume>363</volume><fpage>1341</fpage><lpage>1345</lpage><pub-id pub-id-type="pmid">15110490</pub-id><pub-id pub-id-type="doi">10.1016/S0140-6736(04)16043-1</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cipriani</surname><given-names>A</given-names></name><name><surname>Barbui</surname><given-names>C</given-names></name><name><surname>Geddes</surname><given-names>JR</given-names></name></person-group><article-title>Suicide, depression, and antidepressants. Patients and clinicians need to balance benefits and harms</article-title><source>BMJ</source><year>2005</year><volume>330</volume><fpage>373</fpage><lpage>374</lpage><pub-id pub-id-type="pmid">15718515</pub-id><pub-id pub-id-type="doi">10.1136/bmj.330.7488.373</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gunnell</surname><given-names>D</given-names></name><name><surname>Saperia</surname><given-names>J</given-names></name><name><surname>Ashby</surname><given-names>D</given-names></name></person-group><article-title>Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review</article-title><source>BMJ</source><year>2005</year><volume>330</volume><fpage>385</fpage><lpage>388</lpage><pub-id pub-id-type="pmid">15718537</pub-id><pub-id pub-id-type="doi">10.1136/bmj.330.7488.385</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fergusson</surname><given-names>D</given-names></name><name><surname>Doucette</surname><given-names>S</given-names></name><name><surname>Glass</surname><given-names>KC</given-names></name><name><surname>Shapiro</surname><given-names>S</given-names></name><name><surname>Healy</surname><given-names>D</given-names></name><name><surname>Hebert</surname><given-names>P</given-names></name><name><surname>Hutton</surname><given-names>B</given-names></name></person-group><article-title>Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials</article-title><source>BMJ</source><year>2005</year><volume>330</volume><fpage>396</fpage><lpage>399</lpage><pub-id pub-id-type="pmid">15718539</pub-id><pub-id pub-id-type="doi">10.1136/bmj.330.7488.396</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spiegelhalter</surname><given-names>DJ</given-names></name><name><surname>Myles</surname><given-names>JP</given-names></name><name><surname>Jones</surname><given-names>DR</given-names></name><name><surname>Abrams</surname><given-names>KR</given-names></name></person-group><article-title>An introduction to Bayesian methods in health technology assessment</article-title><source>BMJ</source><year>1999</year><volume>319</volume><fpage>508</fpage><lpage>512</lpage><pub-id pub-id-type="pmid">10454409</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Healy</surname><given-names>D</given-names></name><name><surname>Whitaker</surname><given-names>C</given-names></name></person-group><article-title>Antidepressants and suicide: risk-benefit conundrums</article-title><source>J Psychiatry Neurosc</source><year>2003</year><volume>28</volume><fpage>331</fpage><lpage>337</lpage><pub-id pub-id-type="pmid">14517576</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lapierre</surname><given-names>YD</given-names></name></person-group><article-title>Suicidality with selective serotonin reuptake inhibitors: Valid claim?</article-title><source>J Psychiatry Neurosci</source><year>2003</year><volume>28</volume><fpage>340</fpage><lpage>347</lpage><pub-id pub-id-type="pmid">14517577</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aursnes</surname><given-names>I</given-names></name><name><surname>Tvete</surname><given-names>IF</given-names></name><name><surname>Gaasemyr</surname><given-names>J</given-names></name><name><surname>Natvig</surname><given-names>B</given-names></name></person-group><article-title>Clinical efficacies of antihypertensive drugs</article-title><source>Scand Cardiovasc J</source><year>2003</year><volume>37</volume><fpage>72</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">12775305</pub-id><pub-id pub-id-type="doi">10.1080/14017430310001186</pub-id></citation></ref><ref id="B10"><citation citation-type="other"><article-title>FDA issues public health advisory on cautions for use of antidepressants in adults and children</article-title><ext-link ext-link-type="uri" xlink:href="http://www.fda.gov/bbs/topics/ANSWERS/2004/ANS01283.html"></ext-link></citation></ref></ref-list></back></article>